- 全部删除
您的购物车当前为空
Ibritumomab 是一种鼠源抗 CD20 单克隆抗体,通过在靶细胞和周边组织内形成自由基来杀伤肿瘤细胞。Ibritumomab 可用于研究非霍奇金淋巴瘤。

为众多的药物研发团队赋能,
让新药发现更简单!
Ibritumomab 是一种鼠源抗 CD20 单克隆抗体,通过在靶细胞和周边组织内形成自由基来杀伤肿瘤细胞。Ibritumomab 可用于研究非霍奇金淋巴瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,360 | In stock | |
| 5 mg | ¥ 3,380 | In stock | |
| 10 mg | ¥ 4,930 | In stock | |
| 25 mg | ¥ 7,760 | In stock | |
| 50 mg | ¥ 9,870 | In stock | |
| 100 mg | ¥ 13,300 | In stock |
Ibritumomab 相关产品
| 产品描述 | Ibritumomab is a murine-derived anti-CD20 monoclonal antibody that kills tumor cells by forming free radicals in target cells and surrounding tissues.Ibritumomab is used in the study of non-Hodgkin's lymphoma. |
| 别名 | 替伊莫单抗 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容